We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Liquid Media Found Practical for Diarrheagenic Parasite

By LabMedica International staff writers
Posted on 12 Dec 2011
A common protozoan in the human intestinal tract that can cause the so-called blastocystosis characterized by diarrhea, can be grown in liquid culture media. More...


In vitro culture methods could be safe alternatives to identify Blastocystis hominis for both clinical diagnosis and field study purposes, as present methods are potentially toxic to laboratory personnel.

Scientists at Xi’an Jiaotong University (China) isolated eight samples of B. hominis from symptomatic patient fresh stool samples. More than five B. hominis cells were seen per high-power magnification field. To determine whether in vitro culture could be an environmentally safe alternative, the culture growth of B. hominis observed and compared in three commercially available liquid media: Roswell Park Memorial Institute (RPMI) 1640, 199 Medium, and Dulbecco's modified Eagle's medium (DMEM). The sensitivity and specificity of these culture methods to identify B. hominis were compared with those of existing methods used clinically.

The anaerobic culture of B. hominis in these media required a total inoculum sizes of no less than 105 cells; pH values ranging from 7.0 to 7.5; concentrations of calf or horse serum ranging from 10% to 30%; and basic antibiotics have to be added. Growth peaking times were at days 3, 6, and 9 at pH 7.5 or days 4 and 8 or 9 at pH 7.0 at 37 °C. No significant differences were noted in multiplication or generation times for the cultivation of B. hominis. In 56 of 398 positive cases, the short-term in vitro culture method achieved the best performance with regard to sensitivity and specificity of the five methods studied. All three culture media were from the Gibco (Carlsbad, CA, USA) range of culture media. B. hominis identification has depended on the discovery of vacuolar, granular, amoebic, or cystic forms in stool samples using wet mount smears, iodine staining, trichrome staining, or iron hematoxylin staining.

The authors concluded that the in vitro culture method had the advantage of environmental safety, convenience in preparation and storage, facility in morphologic discrimination, and outstanding performance in terms of sensitivity and specificity, and could be applied to identify B. hominis for clinical diagnosis except in emergency situations. Prevalence surveys in China suggest that about 6% of patients with diarrhea have blastocystosis. The study was published on November 11, 2011, in the International Journal of Infectious Diseases.

Related Links:

Xi’an Jiaotong University
Gibco



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.